197 related articles for article (PubMed ID: 12786612)
1. New developments in the pathophysiology of gastro-oesophageal reflux disease (GERD): implications for patient management.
Quigley EM
Aliment Pharmacol Ther; 2003 Jun; 17 Suppl 2():43-51. PubMed ID: 12786612
[TBL] [Abstract][Full Text] [Related]
2. Review article: the pathophysiology of gastro-oesophageal reflux disease.
Boeckxstaens GE
Aliment Pharmacol Ther; 2007 Jul; 26(2):149-60. PubMed ID: 17593062
[TBL] [Abstract][Full Text] [Related]
3. Review article: the role of acid suppression in patients with non-erosive reflux disease or functional heartburn.
DeVault KR
Aliment Pharmacol Ther; 2006 Mar; 23 Suppl 1():33-9. PubMed ID: 16483268
[TBL] [Abstract][Full Text] [Related]
4. Review article: the pathophysiology of gastro-oesophageal reflux disease - oesophageal manifestations.
Castell DO; Murray JA; Tutuian R; Orlando RC; Arnold R
Aliment Pharmacol Ther; 2004 Dec; 20 Suppl 9():14-25. PubMed ID: 15527461
[TBL] [Abstract][Full Text] [Related]
5. [The characteristics of esophagogastric junction contractile index in patients with gastroesophageal reflux disease or functional heartburn].
Wang K; Duan LP; Ge Y; Xia ZW; Xu ZJ
Zhonghua Nei Ke Za Zhi; 2016 Apr; 55(4):283-8. PubMed ID: 27030616
[TBL] [Abstract][Full Text] [Related]
6. Review article: physiologic and clinical effects of proton pump inhibitors on non-acidic and acidic gastro-oesophageal reflux.
Miner PB
Aliment Pharmacol Ther; 2006 Mar; 23 Suppl 1():25-32. PubMed ID: 16483267
[TBL] [Abstract][Full Text] [Related]
7. The role of the hiatus hernia in gastro-oesophageal reflux disease.
Gordon C; Kang JY; Neild PJ; Maxwell JD
Aliment Pharmacol Ther; 2004 Oct; 20(7):719-32. PubMed ID: 15379832
[TBL] [Abstract][Full Text] [Related]
8. Current understanding of the mechanisms of gastro-oesophageal reflux disease.
Orlando RC
Drugs; 2006; 66 Suppl 1():1-5; discussion 29-33. PubMed ID: 16869342
[TBL] [Abstract][Full Text] [Related]
9. [Pathogenesis of gastro-esophageal reflux disease].
Oshima T; Miwa H
Nihon Rinsho; 2007 May; 65(5):797-801. PubMed ID: 17511216
[TBL] [Abstract][Full Text] [Related]
10. Review article: approaches to endoscopic-negative reflux disease: part of the GERD spectrum or a unique acid-related disorder?
Tack J; Fass R
Aliment Pharmacol Ther; 2004 Feb; 19 Suppl 1():28-34. PubMed ID: 14725576
[TBL] [Abstract][Full Text] [Related]
11. Oesophageal motility defects associated with nocturnal gastro-oesophageal reflux on proton pump inhibitors.
Fouad YM; Katz PO; Castell DO
Aliment Pharmacol Ther; 1999 Nov; 13(11):1467-71. PubMed ID: 10571603
[TBL] [Abstract][Full Text] [Related]
12. Oesophageal hypersensitivity in Japanese patients with non-erosive gastro-oesophageal reflux diseases.
Miwa H; Minoo T; Hojo M; Yaginuma R; Nagahara A; Kawabe M; Ohkawa A; Asaoka D; Kurosawa A; Ohkusa T; Sato N
Aliment Pharmacol Ther; 2004 Jul; 20 Suppl 1():112-7. PubMed ID: 15298616
[TBL] [Abstract][Full Text] [Related]
13. CYP2C19 pharmacogenetics in the clinical use of proton-pump inhibitors for gastro-oesophageal reflux disease: variant alleles predict gastric acid suppression, but not oesophageal acid exposure or reflux symptoms.
Egan LJ; Myhre GM; Mays DC; Dierkhising RA; Kammer PP; Murray JA
Aliment Pharmacol Ther; 2003 Jun; 17(12):1521-8. PubMed ID: 12823155
[TBL] [Abstract][Full Text] [Related]
14. Non-erosive reflux disease and atypical gastro-oesophageal reflux disease manifestations: treatment results.
Galmiche JP
Drugs; 2006; 66 Suppl 1():7-13; discussion 29-33. PubMed ID: 16869343
[TBL] [Abstract][Full Text] [Related]
15. Pathophysiology of gastroesophageal reflux disease: new understanding in a new era.
Herregods TV; Bredenoord AJ; Smout AJ
Neurogastroenterol Motil; 2015 Sep; 27(9):1202-13. PubMed ID: 26053301
[TBL] [Abstract][Full Text] [Related]
16. Pathophysiology of gastro-oesophageal reflux disease.
De Giorgi F; Palmiero M; Esposito I; Mosca F; Cuomo R
Acta Otorhinolaryngol Ital; 2006 Oct; 26(5):241-6. PubMed ID: 17345925
[TBL] [Abstract][Full Text] [Related]
17. Transient lower oesophageal sphincter relaxations--a pharmacological target for gastro-oesophageal reflux disease?
Hirsch DP; Tytgat GN; Boeckxstaens GE
Aliment Pharmacol Ther; 2002 Jan; 16(1):17-26. PubMed ID: 11856074
[TBL] [Abstract][Full Text] [Related]
18. Alterations confined to the gastro-oesophageal junction: the relationship between low LOSP, TLOSRs, hiatus hernia and acid pocket.
Boeckxstaens GE
Best Pract Res Clin Gastroenterol; 2010 Dec; 24(6):821-9. PubMed ID: 21126696
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of rabeprazole on heartburn symptom resolution in patients with non-erosive and erosive gastro-oesophageal reflux disease: a multicenter study from Japan.
Miwa H; Sasaki M; Furuta T; Koike T; Habu Y; Ito M; Fujiwara Y; Wada T; Nagahara A; Hongo M; Chiba T; Kinoshita Y;
Aliment Pharmacol Ther; 2007 Jul; 26(1):69-77. PubMed ID: 17555423
[TBL] [Abstract][Full Text] [Related]
20. Non-erosive and erosive gastroesophageal reflux diseases: No difference with regard to reflux pattern and motility abnormalities.
Martínek J; Benes M; Hucl T; Drastich P; Stirand P; Spicák J
Scand J Gastroenterol; 2008; 43(7):794-800. PubMed ID: 18584517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
